PTC Therapeutics, Inc. Basic Earnings Per Share, Pro Forma
PTC Therapeutics, Inc. (PTCT) reported Basic Earnings Per Share, Pro Forma of -$5.51 per share for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BasicEarningsPerShareProForma · last filed 2013-08-13
- PTC Therapeutics, Inc. basic earnings per share, pro forma for the quarter ending 2013-06-30 was -$5.51, a 103.28% decline year-over-year.
- PTC Therapeutics, Inc. basic earnings per share, pro forma for the quarter ending 2012-06-30 was $168.00.
| Period end | Basic Earnings Per Share, Pro Forma 3 month | Basic Earnings Per Share, Pro Forma 6 month |
|---|---|---|
| 2013-06-30 | -$5.51 10-Q · filed 2013-08-13 | -$33.26 10-Q · filed 2013-08-13 |
| 2012-06-30 | $168.00 10-Q · filed 2013-08-13 | $133.35 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |